Find Zastaprazan manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

0

CEP/COS

0

JDMF

0

EU WC

0

NDC API

0

VMF

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

0

FDA Orange Book

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Zastaprazan [inn], W9s9kzx5md, Unii-w9s9kzx5md, 2133852-18-1, 1-azetidinyl(8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)methanone, Methanone, 1-azetidinyl(8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)-
Molecular Formula
C22H26N4O
Molecular Weight
362.5  g/mol
InChI Key
FEQFUBYYZYQTOJ-UHFFFAOYSA-N
FDA UNII
W9S9KZX5MD

Zastaprazan
1 2D Structure

Zastaprazan

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
azetidin-1-yl-[8-[(2,6-dimethylphenyl)methylamino]-2,3-dimethylimidazo[1,2-a]pyridin-6-yl]methanone
2.1.2 InChI
InChI=1S/C22H26N4O/c1-14-7-5-8-15(2)19(14)12-23-20-11-18(22(27)25-9-6-10-25)13-26-17(4)16(3)24-21(20)26/h5,7-8,11,13,23H,6,9-10,12H2,1-4H3
2.1.3 InChI Key
FEQFUBYYZYQTOJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=C(C(=CC=C1)C)CNC2=CC(=CN3C2=NC(=C3C)C)C(=O)N4CCC4
2.2 Other Identifiers
2.2.1 UNII
W9S9KZX5MD
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Zastaprazan [inn]

2. W9s9kzx5md

3. Unii-w9s9kzx5md

4. 2133852-18-1

5. 1-azetidinyl(8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)methanone

6. Methanone, 1-azetidinyl(8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)-

7. Schembl20986992

8. Akos040757321

9. Ms-25766

10. Hy-139557

11. Cs-0204155

2.4 Create Date
2019-07-20
3 Chemical and Physical Properties
Molecular Weight 362.5 g/mol
Molecular Formula C22H26N4O
XLogP34.4
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count4
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area49.6
Heavy Atom Count27
Formal Charge0
Complexity526
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more

01

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Metrochem

02

Hanmi Pharmaceutical

South Korea

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IPhEB Russia
Not Confirmed
arrow

Hanmi Pharmaceutical

South Korea

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IPhEB Russia
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

03

Jeil Pharmaceutical Co., Ltd

South Korea

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IPhEB Russia
Not Confirmed
arrow

Jeil Pharmaceutical Co., Ltd

South Korea

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
IPhEB Russia
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

Hanmi Pharmaceutical

South Korea
Health 2.0 Conference
Not Confirmed
arrow

Hanmi Pharmaceutical

South Korea
arrow
Health 2.0 Conference
Not Confirmed

Zastaprazan citrate

Registrant Name : Hanmi Fine Chemical Co., Ltd.

Registration Date : 2025-04-04

Registration Number : 1444-11-ND

Manufacturer Name : Hanmi Fine Chemical Co., Ltd...

Manufacturer Address : 57, Gyeongje-ro, Siheung-si, Gyeonggi-do (1248-10)

blank

02

Health 2.0 Conference
Not Confirmed
arrow
arrow
Health 2.0 Conference
Not Confirmed

Zastaprazan citrate

Registrant Name : Jeil Pharmaceutical Co., Ltd.

Registration Date : 2024-04-24

Registration Number : 1668-25-ND

Manufacturer Name : Jeil Pharmaceutical Co., Ltd...

Manufacturer Address : 7, Cheongganggachang-ro, Baegam-myeon, Cheoin-gu, Yongin-si, Gyeonggi-do (Building B ...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Zastaprazan

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

Zastaprazan is a small molecule drug, which is currently being evaluated in Phase IV clinical studies for the treatment of chronic coronary syndrome.


Lead Product(s): Zastaprazan,Rabeprazole Sodium

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Jeil Pharmaceutical Co., Ltd

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 13, 2026

blank

01

Yonsei University

Country
arrow
IPhEB Russia
Not Confirmed

Yonsei University

Country
arrow
IPhEB Russia
Not Confirmed

Details : Zastaprazan is a small molecule drug, which is currently being evaluated in Phase IV clinical studies for the treatment of chronic coronary syndrome.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

March 13, 2026

blank

Details:

Zastaprazan is a P-CAB (potassium-competitive acid-blocking) candidate, a class of drugs that is replacing existing PPIs (proton pump inhibitors) for peptic ulcer disease, including GERD. Livzon will have rights to JP 1366 (zastaprazan) in China, Taiwan, Hong Kong and Macau.


Lead Product(s): Zastaprazan,Inapplicable

Therapeutic Area: Gastroenterology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Livzon Pharmaceutical Group

Deal Size: $127.5 million Upfront Cash: $15.0 million

Deal Type: Acquisition March 14, 2023

blank

02

Onconic Therapeutics

South Korea
arrow
IPhEB Russia
Not Confirmed

Onconic Therapeutics

South Korea
arrow
IPhEB Russia
Not Confirmed

Details : Zastaprazan is a P-CAB (potassium-competitive acid-blocking) candidate, a class of drugs that is replacing existing PPIs (proton pump inhibitors) for peptic ulcer disease, including GERD. Livzon will have rights to JP 1366 (zastaprazan) in China, Taiwan,...

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : $15.0 million

March 14, 2023

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATE SUPPLIERS

read-more
read-more

01

ChemExpress

China
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

CAS Number : 2892564-07-5

End Use API : Zastaprazan

About The Company : Founded in 2006, ChemExpress provides CRO and CDMO services to pharmaceutical and biotech companies. The company supports small molecules, biologics, and new mo...

Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 2133852-18-1 / Zastaprazan API manufacturers, exporters & distributors?

Zastaprazan manufacturers, exporters & distributors 1

72

PharmaCompass offers a list of Zastaprazan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zastaprazan manufacturer or Zastaprazan supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zastaprazan manufacturer or Zastaprazan supplier.

PharmaCompass also assists you with knowing the Zastaprazan API Price utilized in the formulation of products. Zastaprazan API Price is not always fixed or binding as the Zastaprazan Price is obtained through a variety of data sources. The Zastaprazan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Zastaprazan

Synonyms

Zastaprazan [inn], W9s9kzx5md, Unii-w9s9kzx5md, 2133852-18-1, 1-azetidinyl(8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)methanone, Methanone, 1-azetidinyl(8-(((2,6-dimethylphenyl)methyl)amino)-2,3-dimethylimidazo(1,2-a)pyridin-6-yl)-

Cas Number

2133852-18-1

Unique Ingredient Identifier (UNII)

W9S9KZX5MD

Zastaprazan Manufacturers

A Zastaprazan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zastaprazan, including repackagers and relabelers. The FDA regulates Zastaprazan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zastaprazan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Zastaprazan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Zastaprazan Suppliers

A Zastaprazan supplier is an individual or a company that provides Zastaprazan active pharmaceutical ingredient (API) or Zastaprazan finished formulations upon request. The Zastaprazan suppliers may include Zastaprazan API manufacturers, exporters, distributors and traders.

click here to find a list of Zastaprazan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Zastaprazan KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Zastaprazan Drug Master File in Korea (Zastaprazan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zastaprazan. The MFDS reviews the Zastaprazan KDMF as part of the drug registration process and uses the information provided in the Zastaprazan KDMF to evaluate the safety and efficacy of the drug.

After submitting a Zastaprazan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zastaprazan API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Zastaprazan suppliers with KDMF on PharmaCompass.

Zastaprazan GMP

Zastaprazan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Zastaprazan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zastaprazan GMP manufacturer or Zastaprazan GMP API supplier for your needs.

Zastaprazan CoA

A Zastaprazan CoA (Certificate of Analysis) is a formal document that attests to Zastaprazan's compliance with Zastaprazan specifications and serves as a tool for batch-level quality control.

Zastaprazan CoA mostly includes findings from lab analyses of a specific batch. For each Zastaprazan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Zastaprazan may be tested according to a variety of international standards, such as European Pharmacopoeia (Zastaprazan EP), Zastaprazan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zastaprazan USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty